BOSTON, Feb. 23, 2011 /PRNewswire/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company is set to introduce a new product line consisting of urology surgical and diagnostic instruments. The line will feature approximately 10 instruments, six of which are modifications to current product offerings, and five completely redesigned instruments; all of which have FDA clearance.
Solos’ focus is to strengthen its domestic market share in the industry through the implementation of several strategies and the addition of new product lines throughout 2011. In addition, Solos will continue building product awareness and is currently in the process of updating its corporate website. Finally, the Company plans to expand its research and development efforts to develop new instrumentation to better assist physicians.
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company’s website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE Solos Endoscopy, Inc.
